21.79
price down icon1.40%   -0.31
after-market Handel nachbörslich: 21.78 -0.010 -0.05%
loading

Finanzdaten der Dianthus Therapeutics Inc-Aktie (DNTH)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-09-30
Periodenlänge 3 Monate 3 Monate
Revenues
5.41%
0.874
0.924
Operating Expenses
12.20%
18.72
16.68
Benefits Costs and Expenses
14.62
-
Costs And Expenses
12.20%
18.72
16.68
Operating Income/Loss
13.23%
-17.84
-15.76
Nonoperating Income/Loss
311.24%
4.096
0.996
Income/Loss From Continuing Operations Before Tax
1,588%
-13.75
0.924
Income/Loss From Continuing Operations After Tax
6.88%
-13.75
-14.76
Net Income/Loss
6.88%
-13.75
-14.76
Preferred Stock Dividends And Other Adjustments
-
-
Attributable To Noncontrolling Interest
-
-
Basic Average Shares
556.93%
25.67
3.9069
Diluted Average Shares
556.93%
25.67
3.9069
Basic Earnings Per Share
85.71%
-0.54
-3.78
Diluted Earnings Per Share
85.71%
-0.54
-3.78
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
-
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Kapitalisierung:     |  Volumen (24h):